U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's session.
- TROOPS, Inc. TROO shares surged 14.9% to $4.4250.
- NuScale Power Corporation SMR shares jumped 13.3% to $5.30 after Standard Power chose the company's approved SMR technology and ENTRA1 Energy to support two projects.
- Scholar Rock Holding Corporation SRRK shares climbed 11% to $8.08. Scholar Rock recently announced the completion of enrollment for the Phase 3 SAPPHIRE trial.
- Overstock.com, Inc. OSTK gained 11.4% to $17.51 after Director Marcus Lemonis bought 31,800 shares of the company at an average price of $15.67.
- Edgewise Therapeutics, Inc. EWTX rose 10.4% to $7.46. Edgewise Therapeutics recently started enrollment of GRAND CANYON, a global pivotal study of edg-5506 in individuals with Becker muscular dystrophy.
- Pioneer Natural Resources Company PXD gained 9.8% to $236.09 following a report suggesting Exxon Mobil Corporation XOM is nearing a $60 billion deal to buy the company.
- Stagwell Inc. STGW gained 9.7% to $4.51 after Craig-Hallum initiated coverage on the stock with a Buy rating and announced an $8 price target.
- Oddity Tech Ltd. ODD surged 9.5% to $28.40. BofA Securities recently upgraded ODDITY Tech from Neutral to Buy and lowered the price target from $60 to $37.
- FingerMotion, Inc. FNGR rose 8.5% to $6.24. The company recently responded to a short seller report issued by Capybara Research.
- PDD Holdings Inc. PDD gained 8.5% to $106.84.
- trivago N.V. TRVG gained 8.1% to $1.02.
- Clearway Energy, Inc. CWEN rose 8.1% to $20.29 after BofA Securities upgraded the stock from Neutral to Buy.
- Cytokinetics, Incorporated CYTK climbed 7.5% to $29.54.
- Kura Sushi USA, Inc. KRUS rose 6.7% to $71.75.
- Amneal Pharmaceuticals, Inc. AMRX gained 6.7% to $4.16.
- The Trade Desk, Inc. TTD rose 4.8% to $81.93.
Now Read This: Top 4 Health Care Stocks That Are Preparing To Pump This Quarter
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...